The unresolved puzzle why alanine extensions cause disease

Biological Chemistry

Volumn 394, Issue 8, 2013, Pages 951-963

  Winter, Reno ^a   Liebold, Jens ^a   Schwarz, Elisabeth ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Alanine expansion; Amyloid like fibrils; Intranuclear inclusions; OPMD; PABPN1; Protein misfolding; Proteino pathy

Indexed keywords

ALANINE; GLUTAMINE; POLYADENYLIC ACID BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXL2; TRANSCRIPTION FACTOR ZIC2; UNCLASSIFIED DRUG; AMYLOID; PABPN1 PROTEIN, HUMAN; PROTEIN;

AMINO ACID SEQUENCE; BLEPHAROPHIMOSIS; BLEPHAROPHIMOSIS PTOSIS EPICANTHUS INVERSUS SYNDROME; CONGENITAL DISORDER; EPICANTHUS; ESCHERICHIA COLI; FIBER; GENE AMPLIFICATION; HOLOPROSENCEPHALY; HUMAN; LIFE EXPECTANCY; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PTOSIS; REVIEW; X LINKED MENTAL RETARDATION; ANIMAL; CHEMISTRY; METABOLISM; OCULOPHARYNGEAL MUSCULAR DYSTROPHY;

ANIMALIA;

ALANINE; AMYLOID; ANIMALS; HUMANS; MUSCULAR DYSTROPHY, OCULOPHARYNGEAL; POLY(A)-BINDING PROTEIN I; PROTEIN FOLDING; PROTEINS;

EID: 84881642628     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2013-0112     Document Type: Review

References (91)

1. Abu-Baker, A., Messaed, C., Laganiere, J., Gaspar, C., Brais, B., and Rouleau, G.A. (2003). Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy. Hum. Mol. Genet. 12, 2609-2623. (Pubitemid 37304684)
2. Albrecht, A.N., Kornak, U., Boddrich, A., Suring, K., Robinson, P.N., Stiege, A.C., Lurz, R., Stricker, S., Wanker, E.E., and Mundlos, S. (2004). A molecular pathogenesis for transcription factor associated poly-alanine tract expansions. Hum. Mol. Genet. 13, 2351-2359. (Pubitemid 39377839)
3. Amiel, J., Laudier, B., Attie-Bitach, T., Trang, H., de Pontual, L., Gener, B., Trochet, D., Etchevers, H., Ray, P., Simonneau, M., et al. (2003). Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat. Genet. 33, 459-461. (Pubitemid 36390004)
4. Amiel, J., Trochet, D., Clement-Ziza, M., Munnich, A., and Lyonnet, S. (2004). Polyalanine expansions in human. Hum. Mol. Genet. 13 Spec No 2, R235-243. (Pubitemid 39359908)
5. Anfinsen, C.B. (1973). Principles that govern the folding of protein chains. Science 181, 223-230.
6. Anvar, S.Y., t Hoen, P.A., Venema, A., van der Sluijs, B., van Engelen, B., Snoeck, M., Vissing, J., Trollet, C., Dickson, G., Chartier, A., et al. (2011). Deregulation of the ubiquitinproteasome system is the predominant molecular pathology in OPMD animal models and patients. Skelet Muscle 1, 15.
7. Askanas, V., Serdaroglu, P., Engel, W.K., and Alvarez, R.B. (1991). Immunolocalization of ubiquitin in muscle biopsies of patients with inclusion body myositis and oculopharyngeal muscular dystrophy. Neurosci. Lett. 130, 73-76.
8. Bao, Y.P., Cook, L.J., O'Donovan, D., Uyama, E., and Rubinsztein, D.C. (2002). Mammalian, yeast, bacterial, and chemical chaperones reduce aggregate formation and death in a cell model of oculopharyngeal muscular dystrophy. J. Biol. Chem. 277, 12263-12269. (Pubitemid 34952794)
9. Bao, Y.P., Sarkar, S., Uyama, E., and Rubinsztein, D.C. (2004). Congo red, doxycycline, and HSP70 overexpression reduce aggregate formation and cell death in cell models of oculopharyngeal muscular dystrophy. J. Med. Genet. 41, 47-51. (Pubitemid 38125688)
10. Barbezier, N., Chartier, A., Bidet, Y., Buttstedt, A., Voisset, C., Galons, H., Blondel, M., Schwarz, E., and Simonelig, M. (2011). Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy. EMBO Mol, Med. 3, 35-49.
11. Bauer, P.O. and Nukina, N. (2009). The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies. J. Neurochem. 110, 1737-1765.
12. Becher, M.W., Morrison, L., Davis, L.E., Maki, W.C., King, M.K., Bicknell, J.M., Reinert, B.L., Bartolo, C., and Bear, D.G. (2001). Oculopharyngeal muscular dystrophy in Hispanic new Mexicans. J. Am. Med. Assoc. 286, 2437-2440. (Pubitemid 33098162)
13. Bengoechea, R., Tapia, O., Casafont, I., Berciano, J., Lafarga, M., and Berciano, M.T. (2012). Nuclear speckles are involved in nuclear aggregation of PABPN1 and in the pathophysiology of oculopharyngeal muscular dystrophy. Neurobiol. Dis. 46, 118-129.
14. Berciano, M.T., Villagra, N.T., Ojeda, J.L., Navascues, J., Gomes, A., Lafarga, M., and Carmo-Fonseca, M. (2004). Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus. Hum. Mol. Genet. 13, 829-838. (Pubitemid 38515212)
15. Blondelle, S.E., Forood, B., Houghten, R.A., and Perez-Paya, E. (1997). Polyalanine-based peptides as models for self-associated -pleated-sheet complexes. Biochemistry 36, 8393-8400. (Pubitemid 27297551)
16. Blumen, S.C., Brais, B., Korczyn, A.D., Medinsky, S., Chapman, J., Asherov, A., Nisipeanu, P., Codere, F., Bouchard, J.P., Fardeau, M., et al. (1999). Homozygotes for oculopharyngeal muscular dystrophy have a severe form of the disease. Ann. Neurol. 46, 115-118. (Pubitemid 29314390)
17. Blumen, S.C., Korczyn, A.D., Lavoie, H., Medynski, S., Chapman, J., Asherov, A., Nisipeanu, P., Inzelberg, R., Carasso, R.L., Bouchard, J.P., et al. (2000). Oculopharyngeal MD among Bukhara Jews is due to a founder (GCG)9 mutation in the PABP2 gene. Neurology 55, 1267-1270.
18. Brais, B., Bouchard, J.P., Xie, Y.G., Rochefort, D.L., Chretien, N., Tome, F.M., Lafreniere, R.G., Rommens, J.M., Uyama, E., Nohira, O., et al. (1998). Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat. Genet. 18, 164-167. (Pubitemid 28082465)
19. Brais, B., Rouleau, G.A., Bouchard, J.P., Fardeau, M., and Tome, F.M.S. (1999). Oculopharyngeal muscular dystrophy. Semin. Neurol. 19, 59-66. (Pubitemid 29244832)
20. Brais, B., Xie, Y.G., Sanson, M., Morgan, K., Weissenbach, J., Korczyn, A.D., Blumen, S.C., Fardeau, M., Tome, F.M., Bouchard, J.P., et al. (1995). The oculopharyngeal muscular dystrophy locus maps to the region of the cardiac alpha and beta myosin heavy chain genes on chromosome 14q11.2-q13. Hum. Mol. Genet. 4, 429-434.
21. Brison, N., Tylzanowski, P., and Debeer, P. (2012). Limb skeletal malformations - what the HOX is going on? Eur. J. Med. Genet. 55, 1-7.
22. Brown, S.A., Warburton, D., Brown, L.Y., Yu, C.Y., Roeder, E.R., Stengel-Rutkowski, S., Hennekam, R.C., and Muenke, M. (1998). Holoprosencephaly due to mutations in ZIC2, a homologue of Drosophila odd-paired. Nat. Genet. 20, 180-183. (Pubitemid 28455452)
23. Calado, A., Tome, F.M., Brais, B., Rouleau, G.A., Kuhn, U., Wahle, E., and Carmo-Fonseca, M. (2000). Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA. Hum. Mol. Genet. 9, 2321-2328.
24. Carre, A., Castanet, M., Sura-Trueba, S., Szinnai, G., Van Vliet, G., Trochet, D., Amiel, J., Leger, J., Czernichow, P., Scotet, V., et al. (2007). Polymorphic length of FOXE1 alanine stretch: evidence for genetic susceptibility to thyroid dysgenesis. Hum. Genet. 122, 467-476. (Pubitemid 350148958)
25. Catoire, H., Pasco, M.Y., Abu-Baker, A., Holbert, S., Tourette, C., Brais, B., Rouleau, G.A., Parker, J.A., and Neri, C. (2008). Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1. Hum. Mol. Genet. 17, 2108-2117. (Pubitemid 351911980)
26. Chartier, A., Benoit, B., and Simonelig, M. (2006). A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1. EMBO J. 25, 2253-2262.
27. Chartier, A., Raz, V., Sterrenburg, E., Verrips, C.T., van der Maarel, S.M., and Simonelig, M. (2009). Prevention of oculopharyngeal muscular dystrophy by muscular expression of Llama single-chain intrabodies in vivo. Hum. Mol. Genet. 18, 1849-1859.
28. Chaudhuri, T.K. and Paul, S. (2006). Protein-misfolding diseases and chaperone-based therapeutic approaches. FEBS J. 273, 1331-1349. (Pubitemid 44029101)
29. Chiti, F., Webster, P., Taddei, N., Clark, A., Stefani, M., Ramponi, G., and Dobson, C.M. (1999). Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl. Acad. Sci. USA 96, 3590-3594. (Pubitemid 29168954)
30. Chu, L.W. (2012). Alzheimer's disease: early diagnosis and treatment. Hong Kong Med. J. 18, 228-237.
31. Corbeil-Girard, L.P., Klein, A.F., Sasseville, A.M., Lavoie, H., Dicaire, M.J., Saint-Denis, A., Page, M., Duranceau, A., Codere, F., Bouchard, J.P., et al. (2005). PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions. Neurobiol. Dis. 18, 551-567. (Pubitemid 40332714)
32. Crisponi, L., Deiana, M., Loi, A., Chiappe, F., Uda, M., Amati, P., Bisceglia, L., Zelante, L., Nagaraja, R., Porcu, S., et al. (2001). The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/ epicanthus inversus syndrome. Nat. Genet. 27, 159-166. (Pubitemid 32157442)
33. Davies, J.E., Sarkar, S., and Rubinsztein, D.C. (2006). Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy. Hum. Mol. Genet. 15, 23-31. (Pubitemid 43020101)
34. Davies, J.E., Wang, L., Garcia-Oroz, L., Cook, L.J., Vacher, C., O'Donovan, D.G., and Rubinsztein, D.C. (2005). Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice. Nat. Med. 11, 672-677. (Pubitemid 40868309)
35. Dobson, C.M. (1999). Protein misfolding, evolution and disease. Trends Biochem. Sci. 24, 329-332. (Pubitemid 29421804)
36. Fan, X., Dion, P., Laganiere, J., Brais, B., and Rouleau, G.A. (2001). Oligomerization of polyalanine expanded PABPN1 facilitates nuclear protein aggregation that is associated with cell death. Hum. Mol. Genet. 10, 2341-2351. (Pubitemid 33069540)
37. Fan, X., Messaed, C., Dion, P., Laganiere, J., Brais, B., Karpati, G., and Rouleau, G.A. (2003). HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy. Can. J. Neurol. Sci. 30, 244-251. (Pubitemid 37064521)
38. Fan, X. and Rouleau, G.A. (2003). Progress in understanding the pathogenesis of oculopharyngeal muscular dystrophy. Can. J. Neurol. Sci. 30, 8-14. (Pubitemid 36383208)
39. Fandrich, M. and Dobson, C.M. (2002). The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation. EMBO J. 21, 5682-5690. (Pubitemid 35315268)
40. Fandrich, M., Fletcher, M.A., and Dobson, C.M. (2001). Amyloid fibrils from muscle myoglobin. Nature 410, 165-166.
41. Forood, B., Perez-Paya, E., Houghten, R.A., and Blondelle, S.E. (1995). Formation of an extremely stable polyalanine -sheet macromolecule. Biochem. Biophys. Res. Commun. 211, 7-13.
42. Gaspar, C., Jannatipour, M., Dion, P., Laganiere, J., Sequeiros, J., Brais, B., and Rouleau, G.A. (2000). CAG tract of MJD-1 may be prone to frameshifts causing polyalanine accumulation. Hum. Mol. Genet. 9, 1957-1966. (Pubitemid 30642660)
43. Gehring, W.J., Affolter, M., and Burglin, T. (1994). Homeodomain proteins. Annu. Rev. Biochem. 63, 487-526. (Pubitemid 24218641)
44. Goldschmidt, L., Teng, P.K., Riek, R., and Eisenberg, D. (2010). Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc. Natl. Acad. Sci. USA 107, 3487-3492.
45. Goodman, F.R., Bacchelli, C., Brady, A.F., Brueton, L.A., Fryns, J.P., Mortlock, D.P., Innis, J.W., Holmes, L.B., Donnenfeld, A.E., Feingold, M., et al. (2000). Novel HOXA13 mutations and the phenotypic spectrum of hand-foot-genital syndrome. Am. J. Hum. Genet. 67, 197-202. (Pubitemid 30481556)
46. Goodman, F.R., Mundlos, S., Muragaki, Y., Donnai, D., Giovannucci- Uzielli, M.L., Lapi, E., Majewski, F., McGaughran, J., McKeown, C., Reardon, W., et al. (1997). Synpolydactyly phenotypes correlate with size of expansions in HOXD13 polyalanine tract. Proc. Natl. Acad. Sci. USA 94, 7458-7463. (Pubitemid 27345337)
47. Hino, H., Araki, K., Uyama, E., Takeya, M., Araki, M., Yoshinobu, K., Miike, K., Kawazoe, Y., Maeda, Y., Uchino, M., et al. (2004). Myopathy phenotype in transgenic mice expressing mutated PABPN1 as a model of oculopharyngeal muscular dystrophy. Hum. Mol. Genet. 13, 181-190. (Pubitemid 38111356)
48. Invernizzi, G., Papaleo, E., Sabate, R., and Ventura, S. (2012). Protein aggregation: mechanisms and functional consequences. Int. J. Biochem. Cell. Biol. 44, 1541-1554.
49. Jakob-Roetne, R. and Jacobsen, H. (2009). Alzheimer's disease: from pathology to therapeutic approaches. Angew Chem. Int. Ed. Engl. 48, 3030-3059.
50. Kerwitz, Y., Kuhn, U., Lilie, H., Knoth, A., Scheuermann, T., Friedrich, H., Schwarz, E., and Wahle, E. (2003). Stimulation of poly(A) polymerase through a direct interaction with the nuclear poly(A) binding protein allosterically regulated by RNA. EMBO J. 22, 3705-3714. (Pubitemid 36898347)
51. Kim, Y.J., Noguchi, S., Hayashi, Y.K., Tsukahara, T., Shimizu, T., and Arahata, K. (2001). The product of an oculopharyngeal muscular dystrophy gene, poly(A)-binding protein 2, interacts with SKIP and stimulates muscle-specific gene expression. Hum. Mol. Genet. 10, 1129-1139. (Pubitemid 32487536)
52. Klein, A.F., Ebihara, M., Alexander, C., Dicaire, M.J., Sasseville, A.M., Langelier, Y., Rouleau, G.A., and Brais, B. (2008). PABPN1 polyalanine tract deletion and long expansions modify its aggregation pattern and expression. Exp. Cell Res. 314, 1652-1666.
53. Kuhn, U. and Wahle, E. (2004). Structure and function of poly(A) binding proteins. Biochim. Biophys. Acta. 1678, 67-84. (Pubitemid 38626168)
54. Laumonnier, F., Ronce, N., Hamel, B.C., Thomas, P., Lespinasse, J., Raynaud, M., Paringaux, C., Van Bokhoven, H., Kalscheuer, V., Fryns, J.P., et al. (2002). Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency. Am. J. Hum. Genet. 71, 1450-1455. (Pubitemid 36015898)
55. Lavoie, H., Debeane, F., Trinh, Q.D., Turcotte, J.F., Corbeil-Girard, L.P., Dicaire, M.J., Saint-Denis, A., Page, M., Rouleau, G.A., and Brais, B. (2003). Polymorphism, shared functions and convergent evolution of genes with sequences coding for polyalanine domains. Hum. Mol. Genet. 12, 2967-2979. (Pubitemid 37442025)
56. Levy, Y., Jortner, J., and Becker, O.M. (2001). Solvent effects on the energy landscapes and folding kinetics of polyalanine. Proc. Natl. Acad. Sci. USA 98, 2188-2193. (Pubitemid 32209457)
57. Lodderstedt, G., Hess, S., Hause, G., Scheuermann, T., Scheibel, T., and Schwarz, E. (2007). Effect of oculopharyngeal muscular dystrophy-associated extension of seven alanines on the fibrillation properties of the N-terminal domain of PABPN1. FEBS J. 274, 346-355. (Pubitemid 46046645)
58. Lodderstedt, G., Sachs, R., Faust, J., Bordusa, F., Kuhn, U., Golbik, R., Kerth, A., Wahle, E., Balbach, J., and Schwarz, E. (2008). Hofmeister salts and potential therapeutic compounds accelerate in vitro fibril formation of the N-terminal domain of PABPN1 containing a disease-causing alanine extension. Biochemistry 47, 2181-2189. (Pubitemid 351287144)
59. Marqusee, S., Robbins, V.H., and Baldwin, R.L. (1989). Unusually stable helix formation in short alanine-based peptides. Proc. Natl. Acad. Sci. USA 86, 5286-5290.
60. Messaed, C., Dion, P.A., Abu-Baker, A., Rochefort, D., Laganiere, J., Brais, B., and Rouleau, G.A. (2007). Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy. Neurobiol. Dis. 26, 546-557. (Pubitemid 46778990)
61. Miller, J.S., Kennedy, R.J., and Kemp, D.S. (2001). Short, solubilized polyalanines are conformational chameleons: exceptionally helical if N- and C-capped with helix stabilizers, weakly to moderately helical if capped with rigid spacers. Biochemistry 40, 305-309. (Pubitemid 32061976)
62. Mundlos, S., Otto, F., Mundlos, C., Mulliken, J.B., Aylsworth, A.S., Albright, S., Lindhout, D., Cole, W.G., Henn, W., Knoll, J.H., et al. (1997). Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89, 773-779. (Pubitemid 27516180)
63. Muragaki, Y., Mundlos, S., Upton, J., and Olsen, B.R. (1996). Altered growth and branching patterns in synpolydactyly caused by mutations in HOXD13. Science 272, 548-551. (Pubitemid 26138198)
64. Nagai, T., Aruga, J., Takada, S., Gunther, T., Sporle, R., Schughart, K., and Mikoshiba, K. (1997). The expression of the mouse Zic1, Zic2, and Zic3 gene suggests an essential role for Zic genes in body pattern formation. Dev. Biol. 182, 299-313. (Pubitemid 27145481)
65. Nasrallah, I.M., Minarcik, J.C., and Golden, J.A. (2004). A polyalanine tract expansion in Arx forms intranuclear inclusions and results in increased cell death. J. Cell Biol. 167, 411-416. (Pubitemid 39489049)
66. Nemeth, A., Krause, S., Blank, D., Jenny, A., Jeno, P., Lustig, A., and Wahle, E. (1995). Isolation of genomic and cDNA clones encoding bovine poly(A) binding protein II. Nucleic Acids Res. 23, 4034-4041.
67. Nguyen, H.D. and Hall, C.K. (2005). Kinetics of fibril formation by polyalanine peptides. J. Biol. Chem. 280, 9074-9082. (Pubitemid 40409601)
68. Parodi, S., Vollono, C., Baglietto, M.P., Balestri, M., Di Duca, M., Landri, P.A., Ceccherini, I., Ottonello, G., and Cilio, M.R. (2010). Congenital central hypoventilation syndrome: genotypephenotype correlation in parents of affected children carrying a PHOX2B expansion mutation. Clin. Genet. 78, 289-293.
69. Perie, S., Mamchaoui, K., Mouly, V., Blot, S., Bouazza, B., Thornell, L.E., St Guily, J.L., and Butler-Browne, G. (2006). Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy: therapeutic perspectives of autologous myoblast transplantation. Neuromuscul. Disord. 16, 770-781. (Pubitemid 44646861)
70. Rohrberg, J., Sachs, R., Lodderstedt, G., Sackewitz, M., Balbach, J., and Schwarz, E. (2008). Monitoring fibril formation of the N-terminal domain of PABPN1 carrying an alanine repeat by tryptophan fluorescence and real-time NMR. FEBS Lett. 582, 1587-1592.
71. Sackewitz, M., Scheidt, H.A., Lodderstedt, G., Schierhorn, A., Schwarz, E., and Huster, D. (2008). Structural and dynamical characterization of fibrils from a disease-associated alanine expansion domain using proteolysis and solid-state NMR spectroscopy. J. Am. Chem. Soc. 130, 7172-7173. (Pubitemid 351813179)
72. Sasseville, A.M., Caron, A.W., Bourget, L., Klein, A.F., Dicaire, M.J., Rouleau, G.A., Massie, B., Langelier, Y., and Brais, B. (2006). The dynamism of PABPN1 nuclear inclusions during the cell cycle. Neurobiol. Dis. 23, 621-629. (Pubitemid 44234098)
73. Scheuermann, T., Schulz, B., Blume, A., Wahle, E., Rudolph, R., and Schwarz, E. (2003). Trinucleotide expansions leading to an extended poly-L-alanine segment in the poly (A) binding protein PABPN1 cause fibril formation. Protein Sci. 12, 2685-2692. (Pubitemid 37445094)
74. Scully, T. (2012). Demography: to the limit. Nature 492, S2-3.
75. Shinchuk, L.M., Sharma, D., Blondelle, S.E., Reixach, N., Inouye, H., and Kirschner, D.A. (2005). Poly-(L-alanine) expansions form core -sheets that nucleate amyloid assembly. Proteins 61, 579-589. (Pubitemid 41547414)
76. Stromme, P., Mangelsdorf, M.E., Shaw, M.A., Lower, K.M., Lewis, S.M., Bruyere, H., Lutcherath, V., Gedeon, A.K., Wallace, R.H., Scheffer, I.E., et al. (2002). Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy. Nat. Genet. 30, 441-445.
77. Tavanez, J.P., Bengoechea, R., Berciano, M.T., Lafarga, M., Carmo- Fonseca, M., and Enguita, F.J. (2009). Hsp70 chaperones and type I PRMTs are sequestered at intranuclear inclusions caused by polyalanine expansions in PABPN1. PLoS One 4, e6418.
78. Tavanez, J.P., Calado, P., Braga, J., Lafarga, M., and Carmo- Fonseca, M. (2005). In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1. RNA 11, 752-762. (Pubitemid 40594340)
79. Tomaz, R.A., Sousa, I., Silva, J.G., Santos, C., Teixeira, M.R., Leite, V., and Cavaco, B.M. (2012). FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility. Clin. Endocrinol (Oxf) 77, 926-933.
80. Tome, F.M., Chateau, D., Helbling-Leclerc, A., and Fardeau, M. (1997). Morphological changes in muscle fibers in oculopharyngeal muscular dystrophy. Neuromuscul. Disord. 7 (Suppl. 1), S63-69.
81. Toulouse, A., Au-Yeung, F., Gaspar, C., Roussel, J., Dion, P., and Rouleau, G.A. (2005). Ribosomal frameshifting on MJD-1 transcripts with long CAG tracts. Hum. Mol. Genet. 14, 2649-2660. (Pubitemid 41300638)
82. Trollet, C., Anvar, S.Y., Venema, A., Hargreaves, I.P., Foster, K., Vignaud, A., Ferry, A., Negroni, E., Hourde, C., et al. (2010). Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres. Hum. Mol. Genet. 19, 2191-2207.
83. Uversky, V.N. (2010). Mysterious oligomerization of the amyloidogenic proteins. FEBS J. 277, 2940-2953.
84. Uyama, E., Tsukahara, T., Goto, K., Kurano, Y., Ogawa, M., Kim, Y.J., Uchino, M., and Arahata, K. (2000). Nuclear accumulation of expanded PABP2 gene product in oculopharyngeal muscular dystrophy. Muscle Nerve 23, 1549-1554.
85. Verheesen, P., de Kluijver, A., van Koningsbruggen, S., de Brij, M., de Haard, H.J., van Ommen, G.J., van der Maarel, S.M., and Verrips, C.T. (2006). Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear polyA-binding protein with a single-domain intracellular antibody. Hum. Mol. Genet. 15, 105-111. (Pubitemid 43020109)
86. Victor, M., Hayes, R., and Adams, R.D. (1962). Oculopharyngeal muscular dystrophy. A familial disease of late life characterized by dysphagia and progressive ptosis of the evelids. N. Engl. J. Med. 267, 1267-1272.
87. Wang, Q. and Bag, J. (2006). Ectopic expression of a polyalanine expansion mutant of poly(A)-binding protein N1 in muscle cells in culture inhibits myogenesis. Biochem. Biophys. Res. Commun. 340, 815-822. (Pubitemid 43053902)
88. Wang, Q., Mosser, D.D., and Bag, J. (2005). Induction of HSP70 expression and recruitment of HSC70 and HSP70 in the nucleus reduce aggregation of a polyalanine expansion mutant of PABPN1 in HeLa cells. Hum. Mol. Genet. 14, 3673-3684. (Pubitemid 41754667)
89. Wimo, A., Winblad, B., and Jonsson, L. (2010). The worldwide societal costs of dementia: estimates for 2009. Alzheimers Dement. 6, 98-103.
90. Winter, R., Kuhn, U., Hause, G., and Schwarz, E. (2012). Polyalanine-independent conformational conversion of nuclear poly(A)-binding protein 1 (PABPN1). J. Biol. Chem. 287, 22662-22671.
91. Woods, K.S., Cundall, M., Turton, J., Rizotti, K., Mehta, A., Palmer, R., Wong, J., Chong, W.K., Al-Zyoud, M., El-Ali, M., et al. (2005). Over- and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism. Am. J. Hum. Genet. 76, 833-849. (Pubitemid 40563104)